Provided by Tiger Fintech (Singapore) Pte. Ltd.

Parnell Pharmaceuticals

1.00
0.0000
Volume:- -
Turnover:- -
Market Cap:13.28M
PE:-1.30
High:1.00
Open:1.00
Low:1.00
Close:1.00
Loading ...

Company Profile

Company Name:
Parnell Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal — U.S, Production Animal — Rest of World, and Manufacturing Operations. It markets various products, which include estroPLAN and GONAbreed reproductive hormone products for breeding programs in dairy and beef cows; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; Glyde, a nutraceutical product aids for the treatment of OA in dogs; and Tergive, an injectable non-steroidal anti-inflammatory drug that contains carprofen. The company is also developing various products consisting of PAR121 for bone-related diseases and injuries in dogs, cats, and horses; PAR081 for general anesthesia and sedation in dogs and cats, as well as in humans; PAR101 for laminitis in horses and diabetes in dogs; PAR061, an injectable antimicrobial prodrug for mastitis in cattle; GONADOPRO for cattle fertility; and PAR122 for atopic dermatitis and other dermatological conditions. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.